Anlotinib (AL3818) plus pemetrexed in patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A single-arm, open-label, phase II study.

被引：0
|
作者：
Zhang, Yanna
Chen, Jueming
Wei, Wei
Zheng, Lie
Li, Han
Feng, Yanling
Wan, Ting
Qiu, Jiaqi
Jiang, Xingyu
Xiong, Ying
Li, Jundong
Song, Libing
Liu, Jihong
Huang, He
机构：
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Gynecol Oncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Imaging, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Biotherapy, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18078
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TORIPALIMAB PLUS CHEMORADIOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL
    Xu, Xiaoting
    Huan, Jian
    Miao, Hui
    Wang, Hao
    Wang, Yue
    Zhu, Hongyu
    Jiang, Jun
    Zhou, Juying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A384 - A384
  • [32] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [33] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Anlotinib in combination with TQB2450 in patients with recurrent ovarian cancer (ACTION): A multicenter, single-arm, open-label, phase Ib trial.
    Lan, Chunyan
    Zhao, Jing
    Yang, Fan
    Li, Rong
    Huang, Yu
    Wang, Jing
    Zhao, Weihong
    Zhang, Li
    Liu, Chang
    Bi, Xuehan
    Jin, Haihong
    Meng, Jin
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
    Bell-McGuinn, Katherine M.
    Matthews, Carolyn M.
    Ho, Steffan N.
    Barve, Minal
    Gilbert, Lucy
    Penson, Richard T.
    Lengyel, Ernst
    Palaparthy, Rameshraja
    Gilder, Kye
    Vassos, Artemios
    McAuliffe, William
    Weymer, Sara
    Barton, Jeremy
    Schilder, Russell J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (02) : 273 - 279
  • [36] PRELIMINARY RESULTS OF ANLOTINIB AND NIRAPARIB DUAL THERAPY EVALUATION IN PLATINUM-RESISTANT RECURRENT OVARIAN CANCER (ANNIE): A MULTICENTER, SINGLE-ARM, PHASE 2 TRIAL
    Liu, Guochen
    Liu, Jihong
    Xian, Bingna
    Feng, Yanling
    Huang, Qidan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A58 - A58
  • [37] A single arm phase II study of single agent Pemetrexed in platinum resistant/refractory epithelial ovarian or primary peritoneal cancer
    Upadhya, S.
    Khurana, S.
    Kumar, A.
    Malik, P. S.
    Pramanik, R.
    Kataria, B.
    Mathur, S.
    Kumar, M.
    Bhatla, N.
    Ray, M.
    ANNALS OF ONCOLOGY, 2024, 35
  • [38] A single arm phase II study of single agent pemetrexed in platinum resistant/ refractory epithelial ovarian or primary peritoneal cancer
    Parampalli, S.
    Khurana, S.
    Kumar, A.
    Malik, P.
    Pramanik, R.
    Mathur, S.
    Kumar, M.
    Bhatla, N.
    Ray, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1598 - S1598
  • [39] Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study
    Fu, Xiaoyu
    Zhang, Yan
    Wang, Xiaohui
    Chen, Meixia
    Wang, Yao
    Nie, Jing
    Meng, Yuanguang
    Han, Weidong
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2015, 16 (04) : 329 - 336
  • [40] Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
    Song, Zhengbo
    Lou, Guangyuan
    Wang, Yina
    Yang, Zhiping
    Wang, Wenxian
    Ji, Yongling
    Chen, Shiqing
    Xu, Chunwei
    Hu, Xiao
    Zhang, Yiping
    BMC MEDICINE, 2022, 20 (01)
12345